A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

NCT01224106 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

799

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Gantenerumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche